The Cochrane Library: Cochrane Database of Systematic Reviews

DOI: 10.1002/14651858

Reviews/Protocols listed by Cochrane Review Group


  1. Cochrane Acute Respiratory Infections Group
  2. Cochrane Airways Group
  3. Cochrane Anaesthesia, Critical and Emergency Care Group
  4. Cochrane Back and Neck Group
  5. Cochrane Bone, Joint and Muscle Trauma Group
  6. Cochrane Breast Cancer Group
  7. Cochrane Childhood Cancer Group
  8. Cochrane Colorectal Cancer Group
  9. Cochrane Common Mental Disorders Group
  10. Cochrane Consumers and Communication Group
  11. Cochrane Cystic Fibrosis and Genetic Disorders Group
  12. Cochrane Dementia and Cognitive Improvement Group
  13. Cochrane Developmental, Psychosocial and Learning Problems Group
  14. Cochrane Drugs and Alcohol Group
  15. Cochrane Effective Practice and Organisation of Care Group
  16. Cochrane ENT Group
  17. Cochrane Epilepsy Group
  18. Cochrane Eyes and Vision Group
  19. Cochrane Fertility Regulation Group
  20. Cochrane Gynaecological, Neuro-oncology and Orphan Cancer Group
  21. Cochrane Gynaecology and Fertility Group
  22. Cochrane Haematological Malignancies Group
  23. Cochrane Heart Group
  24. Cochrane Hepato-Biliary Group
  25. Cochrane HIV/AIDS Group
  26. Cochrane Hypertension Group
  27. Cochrane IBD Group
    1. About this group
    2. Reviews
      1. Acupuncture for treatment of irritable bowel syndromeReview
      2. Aminosalicylates for induction of remission or response in Crohn's diseaseReview
      3. Anti-IL-12/23p40 antibodies for induction of remission in Crohn's diseaseReview
      4. Anti-tuberculous therapy for maintenance of remission in Crohn's diseaseReview
      5. Antibiotic treatment for Clostridium difficile-associated diarrhoea in adultsReview
      6. Antidepressants for the treatment of abdominal pain-related functional gastrointestinal disorders in children and adolescentsReview
      7. Azathioprine and 6-mercaptopurine for maintenance of remission in ulcerative colitisReview
      8. Azathioprine and 6-mercaptopurine for maintenance of surgically-induced remission in Crohn's diseaseReview
      9. Azathioprine or 6-mercaptopurine for induction of remission in Crohn's diseaseReview
      10. Azathioprine or 6-mercaptopurine for maintenance of remission in Crohn's diseaseReview
      11. Biofeedback for treatment of chronic idiopathic constipation in adultsReview
      12. Budesonide for induction of remission in Crohn's diseaseReview
      13. Budesonide for maintenance of remission in Crohn's diseaseReview
      14. Bulking agents, antispasmodics and antidepressants for the treatment of irritable bowel syndromeReview
      15. Corticosteroids for maintenance of remission in Crohn's diseaseReview
      16. Curcumin for maintenance of remission in ulcerative colitisReview
      17. Cyclosporine A for induction of remission in severe ulcerative colitisReview
      18. Cyclosporine for induction of remission in Crohn's diseaseReview
      19. Endoscopic scoring indices for evaluation of disease activity in Crohn’s diseaseReviewMethodology
      20. Enteral nutrition for maintenance of remission in Crohn's diseaseReview
      21. Enteral nutritional therapy for induction of remission in Crohn's diseaseReview
      22. Etrolizumab for induction of remission in ulcerative colitisReview
      23. Fish oil for induction of remission in ulcerative colitisReview
      24. Glutamine for induction of remission in Crohn's diseaseReview
      25. Helminth therapy (worms) for induction of remission in inflammatory bowel diseaseReview
      26. Herbal medicines for treatment of irritable bowel syndromeReview
      27. Histologic scoring indices for evaluation of disease activity in Crohn’s diseaseReviewMethodologyNew
      28. Histologic scoring indices for evaluation of disease activity in ulcerative colitisReviewMethodology
      29. Homeopathy for treatment of irritable bowel syndromeReview
      30. Human growth hormone and glutamine for patients with short bowel syndromeReview
      31. Hypnotherapy for treatment of irritable bowel syndromeReview
      32. The impact of biological interventions for ulcerative colitis on health-related quality of lifeReview
      33. Interventions for growth failure in childhood Crohn's diseaseReview
      34. Interventions for prevention of post-operative recurrence of Crohn's diseaseReview
      35. Interventions for treating collagenous colitisReview
      36. Interventions for treating lymphocytic colitisReviewNew Search
      37. Low dose naltrexone for induction of remission in Crohn's diseaseReview
      38. Methotrexate for induction of remission in refractory Crohn's diseaseReview
      39. Methotrexate for induction of remission in ulcerative colitisReview
      40. Methotrexate for maintenance of remission in Crohn's diseaseReview
      41. Methotrexate for maintenance of remission in ulcerative colitisReview
      42. Natalizumab for induction of remission in Crohn's diseaseReview
      43. Omega 3 fatty acids (fish oil) for maintenance of remission in Crohn's diseaseReview
      44. Omega 3 fatty acids (fish oil) for maintenance of remission in ulcerative colitisReview
      45. Oral 5-aminosalicylic acid for induction of remission in ulcerative colitisReview
      46. Oral 5-aminosalicylic acid for maintenance of medically-induced remission in Crohn's diseaseReview
      47. Oral 5-aminosalicylic acid for maintenance of remission in ulcerative colitisReview
      48. Oral 5-aminosalicylic acid for maintenance of surgically-induced remission in Crohn's diseaseReview
      49. Oral budesonide for induction of remission in ulcerative colitisReview
      50. Osmotic and stimulant laxatives for the management of childhood constipationReview
      51. Probiotics for induction of remission in Crohn's diseaseReview
      52. Probiotics for induction of remission in ulcerative colitisReview
      53. Probiotics for maintenance of remission in Crohn's diseaseReview
      54. Probiotics for maintenance of remission in ulcerative colitisReview
      55. Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and childrenReview
      56. Probiotics for the prevention of pediatric antibiotic-associated diarrheaReview
      57. Probiotics for treatment of Clostridium difficile-associated colitis in adultsReview
      58. Psychological interventions for treatment of inflammatory bowel diseaseReview
      59. Psychological treatments for the management of irritable bowel syndromeReview
      60. Recombinant human interleukin 10 for induction of remission in Crohn's diseaseReview
      61. Rectal 5-aminosalicylic acid for induction of remission in ulcerative colitisReview
      62. Rectal 5-aminosalicylic acid for maintenance of remission in ulcerative colitisReview
      63. Sargramostim (GM-CSF) for induction of remission in Crohn's diseaseReview
      64. Specialist nursing interventions for inflammatory bowel diseaseReview
      65. Stimulant laxatives for constipation and soiling in childrenReview
      66. Strategies for detecting colon cancer and/or dysplasia in patients with inflammatory bowel diseaseReview
      67. Tacrolimus (FK506) for induction of remission in refractory ulcerative colitisReview
      68. Tegaserod for the treatment of irritable bowel syndrome and chronic constipationReview
      69. Thalidomide and thalidomide analogues for induction of remission in Crohn's diseaseReview
      70. Thalidomide and thalidomide analogues for maintenance of remission in Crohn's diseaseReview
      71. Tolerability of selective cyclooxygenase 2 inhibitors used for the treatment of rheumatological manifestations of inflammatory bowel diseaseReview
      72. Traditional corticosteroids for induction of remission in Crohn's diseaseReview
      73. Transcutaneous electrical stimulation (TES) for treatment of constipation in childrenReview
      74. Transdermal nicotine for induction of remission in ulcerative colitisReview
      75. Treatment and prevention of pouchitis after ileal pouch-anal anastomosis for chronic ulcerative colitisReview
      76. Tumor necrosis factor-alpha antibody for induction of remission in Crohn's diseaseReview
      77. Tumor necrosis factor-alpha antibody for maintenance of remission in Crohn's diseaseReview
      78. Tumour necrosis factor alpha blocking agents for induction of remission in ulcerative colitisReview
      79. Type I interferons for induction of remission in ulcerative colitisReview
      80. Unfractionated or low-molecular weight heparin for induction of remission in ulcerative colitisReview
      81. Vedolizumab for induction and maintenance of remission in ulcerative colitisReview
    3. Protocols
      1. 5-ASA for management of symptomatic uncomplicated diverticular disease (SUDD)Protocol
      2. Abdominal massage for the treatment of constipationProtocol
      3. Acupuncture for chronic constipationProtocol
      4. Adjuvant therapy with antidepressants for the management of inflammatory bowel diseaseProtocolNew
      5. Anti-IL-17 monoclonal antibody for induction of remission in Crohn's diseaseProtocol
      6. Anti-MAdCAM antibody for induction of remission in ulcerative colitisProtocol
      7. Antibiotics for induction and maintenance of remission in Crohn's diseaseProtocolNew
      8. Antibiotics for induction of remission in Crohn's diseaseProtocolWithdrawn
      9. Antibiotics for induction of remission in ulcerative colitisProtocol
      10. Antibiotics for the management of constipation predominant irritable bowel syndrome and chronic constipationProtocol
      11. Antibody development against biologic agents used for the treatment of inflammatory bowel disease and antibody prevention with immunosuppressivesProtocol
      12. Bacille Calmette-Guerin (BCG) vaccine for induction of remission in Crohn's diseaseProtocol
      13. Biofeedback for treatment of irritable bowel syndromeProtocol
      14. Biological interventions for induction of mucosal healing in Crohn’s diseaseProtocolNew
      15. Biological interventions for maintenance of mucosal healing in Crohn’s diseaseProtocolNew
      16. Biomarkers for assessing disease activity in inflammatory bowel diseaseProtocolDiagnostic
      17. Botulinum toxin for the treatment of chronic idiopathic constipationProtocol
      18. Colonoscopy-guided therapy for the prevention of post-operative recurrence of Crohn’s diseaseProtocol
      19. A comparison of endoscopic and surgical treatment of strictures in patients with Crohn’s diseaseProtocol
      20. Cyclosporine for maintenance of remission in Crohn's diseaseProtocol
      21. Endoscopic scoring indices for evaluation of disease activity in ulcerative colitisProtocolMethodology
      22. Fecal transplantation for recurrent or refractory Clostridium difficile diarrheaProtocol
      23. Fiber and bulking agents for the treatment of chronic constipationProtocol
      24. Herbal medicines for the treatment of inflammatory bowel diseaseProtocol
      25. The impact of surgical therapies for inflammatory bowel disease on female fertilityProtocolNew
      26. Infliximab for induction of remission in Crohn's diseaseProtocol
      27. Infliximab for maintenance of remission in Crohn's diseaseProtocol
      28. Interleukin-11 for induction of remission in Crohn's diseaseProtocol
      29. Interventions for fatigue in inflammatory bowel diseaseProtocol
      30. Interventions for induction and maintenance of mucosal healing in Crohn's diseaseProtocol
      31. Interventions for induction of mucosal healing in ulcerative colitisProtocol
      32. Interventions for maintenance of mucosal healing in ulcerative colitisProtocol
      33. MRI scoring indices for evaluation of disease activity and severity in Crohn’s diseaseProtocolMethodology
      34. Mycophenolate mofetil for induction of remission in Crohn's diseaseProtocol
      35. Oral corticosteroids for induction of remission in ulcerative colitisProtocol
      36. Oral janus kinase inhibitors for induction of remission in ulcerative colitisProtocol
      37. Oral janus kinase inhibitors for maintenance of remission in ulcerative colitisProtocol
      38. Pharmacological interventions for the prevention and treatment of radiation colitis, enteritis and proctitisProtocolWithdrawn
      39. Physical activity for treatment of irritable bowel syndromeProtocol
      40. Placebo response and remission rates in randomised trials of induction and maintenance therapy for Crohn’s diseaseProtocolWithdrawn
      41. Placebo response and remission rates in randomized trials of induction and maintenance therapy for ulcerative colitisProtocol
      42. Polyethylene glycol for chronic constipation in adultsProtocol
      43. Probiotic agents for the treatment of diarrhoea-predominant irritable bowel syndromeProtocol
      44. Prucalopride for the treatment of chronic constipationProtocol
      45. Rectal corticosteroids for induction of remission in ulcerative colitisProtocol
      46. Rectal corticosteroids for maintenance of remission in ulcerative colitisProtocol
      47. Reflexology for treatment of constipationProtocol
      48. Short chain fatty acids (butyrate) for induction of remission in ulcerative colitisProtocol
      49. Somatostatin analogues for treatment of enterocutaneous fistulaProtocol
      50. Traditional Chinese medicinal herbs for induction of remission in ulcerative colitisProtocol
      51. Vedolizumab for induction and maintenance of remission in Crohn’s diseaseProtocol
      52. Vitamin D for the treatment of inflammatory bowel diseaseProtocol
      53. Withdrawal of drug therapy for patients with quiescent Crohn's diseaseProtocol
  28. Cochrane Incontinence Group
  29. Cochrane Infectious Diseases Group
  30. Cochrane Injuries Group
  31. Cochrane Kidney and Transplant Group
  32. Cochrane Lung Cancer Group
  33. Cochrane Metabolic and Endocrine Disorders Group
  34. Cochrane Methodology Review Group
  35. Cochrane Movement Disorders Group
  36. Cochrane Multiple Sclerosis and Rare Diseases of the CNS Group
  37. Cochrane Musculoskeletal Group
  38. Cochrane Neonatal Group
  39. Cochrane Neuromuscular Group
  40. Cochrane Oral Health Group
  41. Cochrane Pain, Palliative and Supportive Care Group
  42. Cochrane Pregnancy and Childbirth Group
  43. Cochrane Public Health Group
  44. Cochrane Schizophrenia Group
  45. Cochrane Skin Group
  46. Cochrane STI Group
  47. Cochrane Stroke Group
  48. Cochrane Tobacco Addiction Group
  49. Cochrane Upper GI and Pancreatic Diseases Group
  50. Cochrane Urology Group
  51. Cochrane Vascular Group
  52. Cochrane Work Group
  53. Cochrane Wounds Group

SEARCH